In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for ...

In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for ...

Researchers reported key differences in atopic dermatitis presentation across racial groups and steps clinicians can take to ...

Turmeric, a common spice, has been used in Eastern medicine for centuries. Studies are now examining the benefits of yellow ...

The combined prevalence of sleep disorders was 43.4% among patients with atopic dermatitis, with variation seen in subgroup analyses.

SAN DIEGO — Patients with atopic dermatitis (AD) are at a significantly higher risk for nonmelanoma skin cancer (NMSC), ...

Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...

A new study conducted by researchers at National Jewish Health has found that early changes in the cheek skin barrier may ...

Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible reset ...

Q1 2025 net product revenue for ZORYVE ® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible ...

Atopic dermatitis (AD) presents as a long-term, recurring inflammatory disorder of the skin, and its characteristic itching significantly affects patients' daily living standards. The research was ...